AMAG Pharmaceuticals, Inc. (AMAG) Misses Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts AMAG Hot Sheet
Price: $13.75 --0%
Financial Fact:
Research and development expenses: 17.12M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Research and development expenses: 17.12M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) reported Q1 EPS of ($1.05), $0.03 worse than the analyst estimate of ($1.02). Revenue for the quarter came in at $13.4 million versus the consensus estimate of $15.25 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- KULR Technology Group (KULR) Misses Q2 EPS by 39c
- LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
